Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab

Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab

Davide Allegrini,1 Raffaele Raimondi,2 Giovanni Montesano,3 Alfredo Borgia,2 Tania Sorrentino,2 Panagiotis Tsoutsanis,2 Mario R Romano1,2 1Eye Center, Humanitas, Bergamo, Italy; 2Department of Biomedical Sciences, Humanitas University, Milano, Italy; 3University of London - Optometry and Visual Scie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Allegrini D, Raimondi R, Montesano G, Borgia A, Sorrentino T, Tsoutsanis P, Romano MR
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
ivt interruption
covid-19
intravitreal injection
bevacizumab
Ophthalmology
RE1-994
Acceso en línea:https://doaj.org/article/858c4ff36d404093b285de3b8f33c482
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares